Cyclerion Therapeutics, Inc. — Director's Dealing 2020

Jun 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclerion Therapeutics, Inc. (CYCN)
CIK: 0001755237
Period of Report: 2020-06-16

Reporting Person: Churchwell Kevin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-16	Stock Option (Right to Buy)	$4.46	A	10000	Acquired	2030-06-16	Common Stock (10000)	Direct

Footnotes

F1: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.